Frequently bought together

Brand : XIBAX

XIBAX 60/MG 28/TAB

Sku : I-026502
Key features
XIBAX 60 MG 28 TAB is a film-coated tablet containing etoricoxib 60 mg as the active ingredient. It selectively inhibits cyclooxygenase‑2 (COX‑2), reducing prostaglandin synthesis to alleviate pain and inflammation while exhibiting relatively less COX‑1 inhibition than nonselective NSAIDs. It is indicated for the symptomatic treatment of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and acute gouty arthritis. Available by prescription as film-coated tablets in a pack of 28.
- Brand: XIBAX
- Active Ingredient: Etoricoxib 60mg
- Strength: 60mg
- Dosage Form: Film-coated tablet
- Pack Size: 28 Tablets
- Route: Oral use
- Prescription Status: Prescription
- Therapeutic Class: Analgesic
- Pharmacological Group: COX-2 Inhibitors
- Drug Class: Selective COX-2 Inhibitor (Coxib) NSAID
- Manufacturer: (Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd
- Country of Origin: Saudi Arabia
- SFDA Registration No.: 1501256665
- Shelf Life: 36 months
- Storage: store below 30°c
- Pain Type: Joint, Muscular
- Nsaid: Yes
- Opioid: No

Frequently bought together

Description

Specification

Indications

Approved Uses

Symptomatic treatment of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute gouty arthritis.

Pharmacology

Mechanism of Action

Selective cyclooxygenase‑2 (COX‑2) inhibition, reducing prostaglandin synthesis and thereby decreasing pain and inflammation with relatively less COX‑1 inhibition than nonselective NSAIDs.